中文 | English
Return
Total: 7 , 1/1
Show Home Prev Next End page: GO
Author:(Mingzhen GUO)

1.Clinical outcome of concurrent chemoradiotherapy with different radiation doses for esophageal carcinoma

Mingzhen ZHOU ; Yuanxiang YU ; Hong GUO ; Dongsheng LI

The Journal of Practical Medicine 2015;(6):940-943

2.Oncomelania hupensis status monitoring in Changzhou City,Jiangsu Prov-ince from 2013 to 2016

Mingzhen HE ; Yiqing XIE ; Hong CHEN ; Yonggen ZOU ; Shiying ZHU ; Yanli GUO

Chinese Journal of Schistosomiasis Control 2017;29(4):520-522

3.Investigation on knowledge,attitude,and practice of schistosomiasis pre-vention and control and infection status in Armed Police Forces stationed along Yangtze River

Mingzhen HE ; Yiqing XIE ; Yanli GUO ; Hong CHEN ; Yonggen ZOU ; Shiying ZHU ; You ZHANG

Chinese Journal of Schistosomiasis Control 2017;29(3):346-348,384

4.Liriodendrininhibits cardiomyocyte apoptosis in acute myocardial infarction rats

Qingliang CHEN ; Zhigang GUO ; Bochen YAO ; Bo LI ; Mingzhen QIN ; Yanqiu SONG ; Nan JIANG

Chinese Journal of Geriatrics 2022;41(3):314-319

5.Clinical analysis of sIgG antibody in children with food intolerance in Qingdao

Guiliang HAO ; Tongling XIE ; Wei LI ; Shuai WANG ; Mingzhen GUO ; Lin ZHAO ; Jianhong DONG ; Jinlian SONG

Chinese Journal of Health Management 2023;17(4):291-295

6.Efficacy and safety of extended dual antiplatelet therapy beyond 12 months after coronary artery bypass grafting

Mingzhen QIN ; Yunpeng BAI ; Xiankun LIU ; Tongyun CHEN ; Qingliang CHEN ; Nan JIANG ; Lianqun WANG ; Qiang WANG ; Zhigang GUO

Chinese Journal of Thoracic and Cardiovascular Surgery 2023;39(12):740-749

7.Establishment of pancreatic mucinous cystadenocarcinoma cell line MCC1 with stable overexpression of miR-224

PENG Xiaobo ; GUO Chengtao ; YING Mingzhen ; LI Jie ; SONG Lele ; WU Yanjun ; ZHAN Lixing ; ZHAN Xianbao

Chinese Journal of Cancer Biotherapy 2018;25(7):721-725

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 7 , 1/1 Show Home Prev Next End page: GO